| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-08-0451 |
| P698 | PubMed publication ID | 19047138 |
| P50 | author | Wonil Oh | Q50617251 |
| Youngchul Sung | Q112576717 | ||
| P2093 | author name string | Jung Yeon Lim | |
| Sin-Soo Jeun | |||
| Sang In Park | |||
| Sang-Hoon Park | |||
| Chang Hyun Jeong | |||
| Seong Muk Kim | |||
| Ji Hyeon Oh | |||
| Moonsup Jeong | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| human umbilical cord mesenchymal stem cell | Q107296600 | ||
| P304 | page(s) | 9614-9623 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | |
| P478 | volume | 68 |
| Q39030703 | A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression |
| Q47561992 | Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer |
| Q34135233 | Advances in mesenchymal stem cell-mediated gene therapy for cancer. |
| Q37639246 | Alternative new mesenchymal stem cell source exerts tumor tropism through ALCAM and N-cadherin via regulation of microRNA-192 and -218 |
| Q35014757 | An MRI-visible non-viral vector bearing GD2 single chain antibody for targeted gene delivery to human bone marrow mesenchymal stem cells. |
| Q34975310 | Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System |
| Q34992268 | Application of human umbilical cord blood-derived mesenchymal stem cells in disease models |
| Q37483966 | Applications of neural and mesenchymal stem cells in the treatment of gliomas |
| Q34333323 | Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues |
| Q38834400 | Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts. |
| Q42639075 | Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro |
| Q39439676 | Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo |
| Q38191865 | Cancer gene therapy using mesenchymal stem cells |
| Q35777795 | Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells |
| Q37833578 | Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? |
| Q37772453 | Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? |
| Q33646687 | Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP) |
| Q58707289 | Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas |
| Q34318157 | Current status of gene therapy for brain tumors. |
| Q38108819 | Cytotherapies in multiple myeloma: a complementary approach to current treatments? |
| Q36215003 | DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer |
| Q37073589 | Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects |
| Q50765097 | Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. |
| Q36185578 | Effect of Transplanting Various Concentrations of a Composite of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronic Acid Hydrogel on Articular Cartilage Repair in a Rabbit Model |
| Q42586818 | Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells |
| Q53026090 | Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice. |
| Q39020389 | Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo |
| Q37707505 | Epigenetic Modification of the CCL5/CCR1/ERK Axis Enhances Glioma Targeting in Dedifferentiation-Reprogrammed BMSCs. |
| Q92451024 | Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2 |
| Q64105995 | Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma |
| Q39676530 | Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro |
| Q92461964 | Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium |
| Q43821375 | Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells |
| Q40726859 | Gene therapy of multiple sclerosis using interferon β-secreting human bone marrow mesenchymal stem cells |
| Q35256103 | Genetically modified mesenchymal stem cells for improved islet transplantation |
| Q38811587 | Glioblastoma-mesenchymal stem cell communication modulates expression patterns of kinin receptors: Possible involvement of bradykinin in information flow |
| Q39840843 | Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. |
| Q39545440 | Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2/caspase pathways |
| Q41709256 | Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy |
| Q50506059 | Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. |
| Q34043094 | Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor. |
| Q52564728 | IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer. |
| Q26853431 | Immunotherapeutic organoids: a new approach to cancer treatment |
| Q42284739 | Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology |
| Q39379196 | In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. |
| Q36402844 | In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution |
| Q45873352 | In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging |
| Q39067499 | Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo |
| Q38648551 | Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors |
| Q48117495 | Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies. |
| Q39644411 | Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy |
| Q37027584 | Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model |
| Q64105864 | Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma |
| Q39649349 | Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth |
| Q42341961 | Letter to the Editor on "Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL". |
| Q35069593 | MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors |
| Q59131876 | MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma |
| Q90196428 | MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells |
| Q39445337 | Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles |
| Q50075766 | Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer. |
| Q39852557 | Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. |
| Q90168903 | Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration |
| Q39863924 | Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine |
| Q93020377 | Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer |
| Q38736947 | Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells |
| Q34676808 | Mesenchymal stem cells at the intersection of cell and gene therapy |
| Q40511505 | Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL. |
| Q41827325 | Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model |
| Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
| Q28473229 | Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma |
| Q39432344 | Mesenchymal stem cells: A new platform for targeting suicide genes in cancer. |
| Q36475443 | Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues |
| Q38885494 | Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy. |
| Q37661559 | Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan |
| Q40585840 | Monitoring adenoviral based gene delivery in rat glioma by molecular imaging |
| Q37473651 | Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery |
| Q47707153 | Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. |
| Q53377318 | Neural differentiation of mesenchymal stem cells influences chemotactic responses to HGF. |
| Q53269695 | Neural differentiation of mesenchymal stem cells influences their chemotactic responses to stromal cell-derived factor-1α. |
| Q37874445 | Non-hematopoietic stem cells as factories for in vivo therapeutic protein production. |
| Q38780337 | PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells |
| Q37585453 | Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma |
| Q30621190 | Pre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer |
| Q30893643 | Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles |
| Q37049935 | Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme. |
| Q52628020 | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging. |
| Q39256130 | Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation |
| Q28076798 | Role of nanotechnology and gene delivery systems in TRAIL-based therapies |
| Q37818222 | Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma |
| Q34343825 | Stem Cells and Regenerative Medicine: Accomplishments to Date and Future Promise |
| Q26771835 | Stem cells as cellular vehicles for gene therapy against glioblastoma |
| Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
| Q37730300 | Stem cells as vectors for antitumour therapy |
| Q34938608 | Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy |
| Q37420576 | Strategies in gene therapy for glioblastoma. |
| Q33843839 | Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer |
| Q35681794 | TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill. |
| Q42241898 | TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice |
| Q93337859 | Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors |
| Q38730195 | Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors |
| Q35153149 | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors |
| Q36059696 | The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme |
| Q36312145 | The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma |
| Q38010997 | The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression |
| Q38788475 | The role of mesenchymal stem cells in oncology and regenerative medicine |
| Q38151262 | The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. |
| Q89769517 | Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery |
| Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
| Q39323223 | Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma |
| Q39198277 | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors |
| Q34480527 | Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma |
| Q35861702 | Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis |
| Q33560685 | Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors |
| Q37640522 | Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly enhanced the antitumor immune response and lifespan in mice |
| Q38016208 | Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention |
| Q36968300 | Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation |
| Q41429938 | Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons |
| Q37948053 | Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q37567452 | Viruses, gene therapy and stem cells for the treatment of human glioma. |
| Q37620389 | Wharton's jelly stromal cells as potential delivery vehicles for cancer therapeutics |
| Q39016914 | p27 modulates tropism of mesenchymal stem cells toward brain tumors |
| Q42368100 | pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo |
Search more.